AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 53 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $467,000 | +51.6% | 23,765 | +11.0% | 0.00% | +100.0% |
Q2 2017 | $308,000 | +63.8% | 21,403 | +4.5% | 0.00% | 0.0% |
Q1 2017 | $188,000 | -23.0% | 20,488 | -12.5% | 0.00% | 0.0% |
Q4 2016 | $244,000 | +22.6% | 23,425 | +6.5% | 0.00% | 0.0% |
Q3 2016 | $199,000 | +26.8% | 21,996 | +5.1% | 0.00% | 0.0% |
Q2 2016 | $157,000 | -16.9% | 20,937 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $189,000 | -8.3% | 20,937 | +31.5% | 0.00% | 0.0% |
Q4 2015 | $206,000 | +38.3% | 15,924 | +3.1% | 0.00% | 0.0% |
Q3 2015 | $149,000 | -6.3% | 15,450 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $159,000 | +156.5% | 15,450 | +176.9% | 0.00% | – |
Q1 2015 | $62,000 | -84.5% | 5,580 | -83.7% | 0.00% | -100.0% |
Q4 2014 | $399,000 | +202.3% | 34,286 | +473.9% | 0.00% | +100.0% |
Q3 2014 | $132,000 | -20.5% | 5,974 | +0.1% | 0.00% | 0.0% |
Q2 2014 | $166,000 | – | 5,971 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 3,100,000 | $15,004,000 | 2.10% |
DAFNA Capital Management LLC | 830,538 | $4,020,000 | 1.51% |
Baupost Group | 24,471,453 | $118,442,000 | 1.07% |
Nantahala Capital Management | 5,789,561 | $28,021,000 | 0.86% |
Old West Investment Management, LLC | 367,870 | $1,780,000 | 0.84% |
Abrams Capital Management | 5,656,462 | $27,377,000 | 0.74% |
Sofinnova Investments, Inc. | 848,356 | $4,106,000 | 0.38% |
Stanley-Laman Group, Ltd. | 312,609 | $1,513,000 | 0.36% |
Nantahala Capital Management | 2,000,000 | $9,680,000 | 0.30% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,494,070 | $7,231,000 | 0.24% |